Levetiracetam
CHEBI:CHEBI_6437
Definition
A pyrrolidinone and carboxamide that is N-methylpyrrolidin-2-one in which one of the methyl hydrogens is replaced by an aminocarbonyl group, while another is replaced by an ethyl group (the S enantiomer). An anticonvulsant, it is used for the treatment of epilepsy in both human and veterinary medicine.
Chemical Information
- Molecular Formula
- C8H14N2O2
- Molecular Mass
- 170.20900
- Charge
- 0
- SMILES
- CC[C@H](N1CCCC1=O)C(N)=O
- InChI
- InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1
- InChIKey
- HPHUVLMMVZITSG-LURJTMIESA-N
Alternative Names
- (-)-(S)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide
- (2S)-2-(2-oxopyrrolidin-1-yl)butanamide
- (S)-(-)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide
- (S)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide
- Keppra
- levetiracetam
- Levetiracetam
- levetiracetamum
- UCB-L 059
Drug Classification
-
pyrrolidin-2-onesView Class →
CHEBI:74223
-
t265648
-
t265983
-
t266423
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- DRON_00010000
- 114477
- oboInOwl#hasDbXref
- Wikipedia:Levetiracetam
- core#notation
- CHEBI:6437
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- product_ndc
- 63187-360
- marketing_start_date
- 20031020
- labeler_name
- Chartwell RX, LLC
- has_treatment
- http://purl.obolibrary.org/obo/DOID_0081421
- application_number
- ANDA090981
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
- dosage_form
- TABLET, FOR SUSPENSION
- package_ndc
- 68180-118-07
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 114477
- oboInOwl#hasDbXref
- Wikipedia:Levetiracetam
- oboInOwl#id
- CHEBI:6437
- brand_name
- Levetiracetam Levetiracetam
- brand_name_base
- LEVETIRACETAM solution
- generic_name
- Levetiracetam (Form-I)
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_35703
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- listing_expiration_date
- 20241231
- spl_id
- abdc51be-118f-4829-900f-f005efedbf7c
- package_description
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (80705-101-30)
- package_marketing_start_date
- 20031020
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect31144
- owl#annotatedSource
- t266445
- owl#someValuesFrom
- t3103247
- route
- INTRAVENOUS
- rxcui
- 1875868
- manufacturer_name
- SOHM, Inc.
- unii
- 44YRR34555
- spl_set_id
- 23e2d43d-0578-4a78-925a-84389842d2db
- core#notation
- CHEBI:6437
- brand_name_suffix
- Extended-Release
- pharm_class_pe
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- pharm_class
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- upc
- 0314789220086
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- nui
- N0000008486
- active_ingredient_strength
- 1500 mg/100mL
- active_ingredient_name
- LEVETIRACETAM